Yuan Lin

Vorstandsvorsitzender bei Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.

36 Jahre

Consumer Services

Health Technology

Profil

Yuan Lin is currently the Chairman & General Manager at Fujian Mindong Rejuenation Pharmaceutical Co., Ltd.
She started this position in 2020.
Prior to her current role, she obtained an MBA from the University of Hong Kong in 2014.
She also completed her undergraduate studies at Renmin University of China.

Aktive Positionen von Yuan Lin

Unternehmen	Position	Beginn
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China.	Vorstandsvorsitzender	01.03.2015

Alle aktiven Positionen von Yuan Lin

Ausbildung von Yuan Lin

Renmin University of China	Undergraduate Degree
University of Hong Kong	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Yuan Lin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujian Mindong Rejuenation Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparations and proprietary Chinese medicines. Its products include citicoline sodium tablets and injection, phenobarbital sodium injection, compound glycyrrhizin injection, and compound taizishen granules. The company was founded on September 24, 1997 and is headquartered in Ningde, China.	Health Technology